US Patent Issued to BIOCRYST PHARMACEUTICALS on March 31 for "Plasma kallikrein inhibitors and methods of use thereof in ocular disorders" (Alabama, Georgia Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,093, issued on March 31, was assigned to BIOCRYST PHARMACEUTICALS INC. (Durham, N.C.).

"Plasma kallikrein inhibitors and methods of use thereof in ocular disorders" was invented by Yarlagadda Babu (Birmingham, Ala.), Viral Kansara (Alpharetta, Ga.) and Rick McElheny (Alpharetta, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure is generally in the field of ophthalmic therapies, and more particularly to the treatment of various ocular diseases and conditions by non-surgical administration to the eye of a subject of a drug composition described herein containing a plasma kallikrein inhibitor. Plasma kallikrein inhibitors include avor...